Literature DB >> 32332850

The vaginal microbiota associates with the regression of untreated cervical intraepithelial neoplasia 2 lesions.

Anita Mitra1,2, David A MacIntyre1,3, George Ntritsos4, Ann Smith5, Konstantinos K Tsilidis4,6, Julian R Marchesi3,7,8, Phillip R Bennett1,2,3, Anna-Barbara Moscicki9, Maria Kyrgiou10,11.   

Abstract

Emerging evidence suggests associations between the vaginal microbiota (VMB) composition, human papillomavirus (HPV) infection, and cervical intraepithelial neoplasia (CIN); however, causal inference remains uncertain. Here, we use bacterial DNA sequencing from serially collected vaginal samples from a cohort of 87 adolescent and young women aged 16-26 years with histologically confirmed, untreated CIN2 lesions to determine whether VMB composition affects rates of regression over 24 months. We show that women with a Lactobacillus-dominant microbiome at baseline are more likely to have regressive disease at 12 months. Lactobacillus spp. depletion and presence of specific anaerobic taxa including Megasphaera, Prevotella timonensis and Gardnerella vaginalis are associated with CIN2 persistence and slower regression. These findings suggest that VMB composition may be a future useful biomarker in predicting disease outcome and tailoring surveillance, whilst it may offer rational targets for the development of new prevention and treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32332850      PMCID: PMC7181700          DOI: 10.1038/s41467-020-15856-y

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  72 in total

1.  Diagnoses and outcomes in cervical cancer screening: a population-based study.

Authors:  Ralph P Insinga; Andrew G Glass; Brenda B Rush
Journal:  Am J Obstet Gynecol       Date:  2004-07       Impact factor: 8.661

2.  Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women.

Authors:  Anna-Barbara Moscicki; Yifei Ma; Charles Wibbelsman; Teresa M Darragh; Adaleen Powers; Sepideh Farhat; Stephen Shiboski
Journal:  Obstet Gynecol       Date:  2010-12       Impact factor: 7.661

Review 3.  The causal relation between human papillomavirus and cervical cancer.

Authors:  F X Bosch; A Lorincz; N Muñoz; C J L M Meijer; K V Shah
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

Review 4.  Human papilloma virus, papanicolaou smears, and the college female.

Authors:  Anna-Barbara Moscicki
Journal:  Pediatr Clin North Am       Date:  2005-02       Impact factor: 3.278

5.  A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion.

Authors:  Martyn Plummer; Mark Schiffman; Philip E Castle; Delphine Maucort-Boulch; Cosette M Wheeler
Journal:  J Infect Dis       Date:  2007-04-16       Impact factor: 5.226

6.  Treatment of cervical precancers: back to basics.

Authors:  Michelle J Khan; Karen K Smith-McCune
Journal:  Obstet Gynecol       Date:  2014-06       Impact factor: 7.661

7.  A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection.

Authors:  L A Koutsky; K K Holmes; C W Critchlow; C E Stevens; J Paavonen; A M Beckmann; T A DeRouen; D A Galloway; D Vernon; N B Kiviat
Journal:  N Engl J Med       Date:  1992-10-29       Impact factor: 91.245

8.  Progression and regression of incident cervical HPV 6, 11, 16 and 18 infections in young women.

Authors:  Ralph P Insinga; Erik J Dasbach; Elamin H Elbasha; Kai-Li Liaw; Eliav Barr
Journal:  Infect Agent Cancer       Date:  2007-07-12       Impact factor: 2.965

Review 9.  Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis.

Authors:  Maria Kyrgiou; Antonios Athanasiou; Maria Paraskevaidi; Anita Mitra; Ilkka Kalliala; Pierre Martin-Hirsch; Marc Arbyn; Phillip Bennett; Evangelos Paraskevaidis
Journal:  BMJ       Date:  2016-07-28

Review 10.  Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis.

Authors:  Karoliina Tainio; Antonios Athanasiou; Kari A O Tikkinen; Riikka Aaltonen; Jovita Cárdenas; Sivan Glazer-Livson; Maija Jakobsson; Kirsi Joronen; Mari Kiviharju; Karolina Louvanto; Sanna Oksjoki; Riikka Tähtinen; Seppo Virtanen; Pekka Nieminen; Maria Kyrgiou; Ilkka Kalliala
Journal:  BMJ       Date:  2018-02-27
View more
  26 in total

Review 1.  Prevotella diversity, niches and interactions with the human host.

Authors:  Adrian Tett; Edoardo Pasolli; Giulia Masetti; Danilo Ercolini; Nicola Segata
Journal:  Nat Rev Microbiol       Date:  2021-05-28       Impact factor: 60.633

Review 2.  Host and Microbiome Interplay Shapes the Vaginal Microenvironment.

Authors:  Myoung Seung Kwon; Heung Kyu Lee
Journal:  Front Immunol       Date:  2022-06-28       Impact factor: 8.786

3.  Vaginal Bacteria and Risk of Incident and Persistent Infection With High-Risk Subtypes of Human Papillomavirus: A Cohort Study Among Kenyan Women.

Authors:  Kayla A Carter; Sujatha Srinivasan; Tina L Fiedler; Omu Anzala; Joshua Kimani; Vernon Mochache; Jacqueline M Wallis; David N Fredricks; R Scott McClelland; Jennifer E Balkus
Journal:  Sex Transm Dis       Date:  2021-07-01       Impact factor: 3.868

4.  Vaginal microbiota and human papillomavirus infection among young Swedish women.

Authors:  Liqin Cheng; Johanna Norenhag; Yue O O Hu; Nele Brusselaers; Emma Fransson; Andreas Ährlund-Richter; Unnur Guðnadóttir; Pia Angelidou; Yinghua Zha; Marica Hamsten; Ina Schuppe-Koistinen; Matts Olovsson; Lars Engstrand; Juan Du
Journal:  NPJ Biofilms Microbiomes       Date:  2020-10-12       Impact factor: 7.290

Review 5.  The Microbiome and Gynecologic Cancer: Current Evidence and Future Opportunities.

Authors:  Laura M Chambers; Parker Bussies; Roberto Vargas; Emily Esakov; Surabhi Tewari; Ofer Reizes; Chad Michener
Journal:  Curr Oncol Rep       Date:  2021-06-14       Impact factor: 5.075

6.  Translocation of vaginal microbiota is involved in impairment and protection of uterine health.

Authors:  Jinfeng Wang; Zhanzhan Li; Xiuling Ma; Lifeng Du; Zhen Jia; Xue Cui; Liqun Yu; Jing Yang; Liwen Xiao; Bing Zhang; Huimin Fan; Fangqing Zhao
Journal:  Nat Commun       Date:  2021-07-07       Impact factor: 14.919

7.  Proteome-wide prediction of bacterial carbohydrate-binding proteins as a tool for understanding commensal and pathogen colonisation of the vaginal microbiome.

Authors:  François Bonnardel; Stuart M Haslam; Anne Dell; Ten Feizi; Yan Liu; Virginia Tajadura-Ortega; Yukie Akune; Lynne Sykes; Phillip R Bennett; David A MacIntyre; Frédérique Lisacek; Anne Imberty
Journal:  NPJ Biofilms Microbiomes       Date:  2021-06-15       Impact factor: 7.290

Review 8.  The interplay between the vaginal microbiome and innate immunity in the focus of predictive, preventive, and personalized medical approach to combat HPV-induced cervical cancer.

Authors:  Erik Kudela; Alena Liskova; Marek Samec; Lenka Koklesova; Veronika Holubekova; Tomas Rokos; Erik Kozubik; Terezia Pribulova; Kevin Zhai; Dietrich Busselberg; Peter Kubatka; Kamil Biringer
Journal:  EPMA J       Date:  2021-05-18       Impact factor: 8.836

Review 9.  The pregnancy microbiome and preterm birth.

Authors:  Erna Bayar; Phillip R Bennett; Denise Chan; Lynne Sykes; David A MacIntyre
Journal:  Semin Immunopathol       Date:  2020-08-14       Impact factor: 9.623

10.  The association between obesity and weight loss after bariatric surgery on the vaginal microbiota.

Authors:  Phillip R Bennett; Maria Kyrgiou; Olivia Raglan; David A MacIntyre; Anita Mitra; Yun S Lee; Ann Smith; Nada Assi; Jaya Nautiyal; Sanjay Purkayastha; Marc J Gunter; Hani Gabra; Julian R Marchesi
Journal:  Microbiome       Date:  2021-05-28       Impact factor: 14.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.